We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMH
2501
UMH Properties
UMH
$1.36B
$2.4M ﹤0.01%
155,398
-7,960
-5% -$134K
CSTE icon
2502
Caesarstone
CSTE
$79.5M
$2.4M ﹤0.01%
174,913
-10,006
-5% -$132K
HYFM icon
2503
Hydrofarm Holdings
HYFM
$7.62M
$2.4M ﹤0.01%
+3,982
New +$2.79M
KDMN
2504
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.4M ﹤0.01%
615,835
-20,076
-3% -$92K
GRC icon
2505
Gorman-Rupp
GRC
$2.21B
$2.38M ﹤0.01%
71,905
-323
-0.4% -$10.7K
PBYI icon
2506
Puma Biotechnology
PBYI
$454M
$2.38M ﹤0.01%
244,367
+102,917
+73% +$1.15M
MBIN icon
2507
Merchants Bancorp
MBIN
$2.49B
$2.34M ﹤0.01%
83,784
+2,817
+3% +$65.3K
CRBP icon
2508
Corbus Pharmaceuticals
CRBP
$190M
$2.34M ﹤0.01%
8,437
+270
+3% +$17.7K
KLRS
2509
Kalaris Therapeutics
KLRS
$96.8M
$2.33M ﹤0.01%
4,336
+883
+26% +$742K
AMSC icon
2510
American Superconductor
AMSC
$1.59B
$2.33M ﹤0.01%
122,670
+8,425
+7% +$209K
LTRPA
2511
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$2.31M ﹤0.01%
362,247
-16,544
-4% -$89.4K
BTAI icon
2512
BioXcel Therapeutics
BTAI
$27.8M
$2.31M ﹤0.01%
3,343
-99
-3% -$79.6K
BHB icon
2513
Bar Harbor Bankshares
BHB
$666M
$2.31M ﹤0.01%
78,360
-963
-1% -$25.1K
VRS
2514
DELISTED
Verso Corporation
VRS
$2.3M ﹤0.01%
157,794
-1,416
-0.9% -$18.6K
ENIC icon
2515
Enel Chile
ENIC
$6.28B
$2.3M ﹤0.01%
587,190
-18,255
-3% -$72K
FORR icon
2516
Forrester Research
FORR
$224M
$2.29M ﹤0.01%
54,025
-1,212
-2% -$52.6K
PENG
2517
Penguin Solutions Inc
PENG
$2.99B
$2.29M ﹤0.01%
99,408
+1,258
+1% +$27.3K
LQDT icon
2518
Liquidity Services
LQDT
$1.32B
$2.28M ﹤0.01%
122,844
-4,867
-4% -$88.1K
TRUE
2519
DELISTED
TrueCar
TRUE
$2.27M ﹤0.01%
473,471
-3,811
-0.8% -$18.9K
MCS icon
2520
Marcus Corp
MCS
$945M
$2.26M ﹤0.01%
113,160
-7,968
-7% -$147K
MOV icon
2521
Movado Group
MOV
$841M
$2.26M ﹤0.01%
79,409
-4,056
-5% -$91.6K
DXPE icon
2522
DXP Enterprises
DXPE
$2.98B
$2.26M ﹤0.01%
74,836
-499
-0.7% -$14.2K
MBWM icon
2523
Mercantile Bank Corp
MBWM
$1.05B
$2.26M ﹤0.01%
69,516
-570
-0.8% -$17.2K
LOVE
2524
LoveSac
LOVE
$261M
$2.25M ﹤0.01%
39,797
+2,191
+6% +$121K
BCAB icon
2525
BioAtla
BCAB
$5.74M
$2.25M ﹤0.01%
+886
New +$2.27M

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.